menu toggle

Report: Biosimilars have significantly lowered prices of all biologics

Biosimilars Forum

Competition from biosimilars has lowered prices on reference biologics by an average of 56%, up to 150%.

More in the Media

Veterinary Advantage, Steve Shell and Julia Loew

Topics Of Conversation For Veterinary Clinics And Their Partners

December 22, 2022

The Center for Biosimilars, Brian Biehn

New Year, New Hurdles: What’s in Store for Biosimilars in 2023

December 19, 2022

Fierce Pharma, Alex Kilgore and Micaela Brandau

Advancing Access to Digital Therapeutics

December 19, 2022

Drug Topics, Ann Anaya and Dean Kathleen Kennedy

Representation Matters: Improving Diversity in Pharmacy

December 07, 2022